CNS Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020

HOUSTON, May 27, 2020 /PRNewswire/ --CNS Pharmaceuticals, Inc., (Nasdaq: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it has received notification from Nasdaq that trading in the Company's common stock will resume on Thursday, May 28, 2020.